US HB3 | 2019-2020 | 116th Congress

Status

Spectrum: Partisan Bill (Democrat 106-1)
Status: Engrossed on December 16 2019 - 50% progression
Action: 2019-12-16 - Received in the Senate.
Text: Latest bill text (Engrossed) [PDF]

Summary

Elijah E. Cummings Lower Drug Costs Now Act This bill establishes several programs and requirements relating to the prices of prescription drugs, health care coverage and costs, and public health. TITLE I--LOWERING PRICES THROUGH FAIR DRUG PRICE NEGOTIATION The bill requires the Department of Health and Human Services (HHS) to negotiate prices for certain drugs. (Under current law, HHS may not negotiate the prices of covered drugs under the Medicare prescription drug benefit.) Specifically, HHS must negotiate maximum prices for (1) insulin products; (2) with respect to FY2023, at least 25 single-source, brand-name drugs that do not have generic competition and that are among either the 125 drugs that account for the greatest national spending or the 125 drugs that account for the greatest spending under the Medicare prescription drug benefit and Medicare Advantage (MA); (3) beginning in FY2024, at least 50 such single-source, brand-name drugs; and (4) newly approved single-source, brand-name drugs that meet or exceed a specified price threshold and that HHS determines are likely to meet the spending criteria. The negotiated prices must be offered under Medicare and MA and may also be offered under private health insurance unless the insurer opts out. The negotiated maximum price may not exceed (1) 120% of the average price in Australia, Canada, France, Germany, Japan, and the United Kingdom; or (2) if such information is not available, 85% of the U.S. average manufacturer price. Drug manufacturers that fail to comply with the bill's negotiation requirements are subject to civil and tax penalties. TITLE II--MEDICARE PARTS B AND D PRESCRIPTION DRUG INFLATION REBATES The bill also requires drug manufacturers, subject to civil penalties, to issue rebates to the Centers for Medicare & Medicaid Services (CMS) for covered drugs under Medicare that cost $100 or more and for which the average manufacturer price increases faster than inflation. TITLE III--PART D IMPROVEMENTS AND MAXIMUM OUT-OF-POCKET CAP FOR MEDICARE BENEFICIARIES The bill reduces the annual out-of-pocket spending threshold, and eliminates beneficiary cost-sharing above this threshold, under the Medicare prescription drug benefit. Additionally, prescription drug plan sponsors must allow certain beneficiaries to make coinsurance payments in periodic installments, in accordance with CMS requirements. TITLE IV--DRUG PRICE TRANSPARENCY Drug manufacturers must report, subject to civil penalties, specified information for certain drugs that cost $100 or more and that are covered under Medicare or Medicaid, based on the rate of price or spending increases. Among other things, manufacturers must report a qualifying price increase at least 30 days before the effective date of the increase; HHS must publish the information on its website the day the increase takes effect. TITLE V--PROGRAM IMPROVEMENTS FOR MEDICARE LOW-INCOME BENEFICIARIES The bill expands eligibility for certain premium and cost-sharing subsidies for low-income beneficiaries under the Medicare prescription drug benefit. For example, the bill (1) raises the maximum allowable income for beneficiaries to qualify, and (2) allows certain residents of U.S. territories to automatically qualify. TITLE VI--PROVIDING FOR DENTAL, VISION, AND HEARING COVERAGE UNDER THE MEDICARE PROGRAM The bill also expands Medicare coverage to include (1) dentures and dental and oral health services, including basic and major treatments (as determined by the CMS) as well as specified preventive and screening services; (2) hearing aids and hearing rehabilitation and treatment services; and (3) eyeglasses, contact lenses, and vision services, including routine eye examinations and contact lens fittings. TITLE VII--NIH, FDA, AND OPIOIDS FUNDING The bill provides additional funds for several public health programs. Among other things, the bill (1) provides specified funds for innovation projects at the National Institutes of Health through FY2030 and for innovation projects at the Food and Drug Administration through FY2029; and (2) establishes the Opioid Epidemic Response Fund to support HHS programs and initiatives, including the State Opioid Response Grant Program. Additionally, HHS must take a series of actions relating to health care administrative costs. Specifically, HHS must develop a strategy and take associated action to reduce unnecessary costs and administrative burdens in the health care system, including Medicare, Medicaid, and the private health-insurance market, by at least half over a period of 10 years. HHS must also award grants so that states may establish commissions targeting such costs. TITLE VIII--MISCELLANEOUS The bill also establishes and revises several other health care programs and requirements. For example, the bill (1) expands guaranteed issue rights with respect to Medigap policies (Medicare supplemental health-insurance policies); (2) provides specified funds for the Community Health Centers Fund through FY2025; (3) establishes grant programs to support mental health and trauma services in schools, as well as career development programs for health professionals; and (4) requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. Additionally, the CMS must issue regulations that require direct-to-consumer television advertisements for all covered drugs and biologics under Medicare and Medicaid to include the list price of a 30-day supply or for a typical course of treatment. (On May 10, 2019, the CMS issued a final rule titled Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency. The rule requires direct-to-consumer television advertisements for covered drugs and biologics under Medicare and Medicaid to include the list price of a 30-day supply or for a typical course of treatment, if the list price is at least $35 per month. The rule was scheduled to take effect July 9, 2019; however, a federal court blocked implementation, citing a lack of statutory authority.)

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Elijah E. Cummings Lower Drug Costs Now Act

Sponsors

Rep. Frank Pallone [D-NJ]Rep. Richard Neal [D-MA]Rep. Robert Scott [D-VA]Rep. John Larson [D-CT]
Rep. Ann Kuster [D-NH]Rep. Diana DeGette [D-CO]Rep. Bobby Rush [D-IL]Rep. Donna Shalala [D-FL]
Rep. Tim Ryan [D-OH]Rep. Joseph Morelle [D-NY]Rep. Gregorio Sablan [I-MP]Rep. Ed Case [D-HI]
Rep. Eliot Engel [D-NY]Rep. Kathy Castor [D-FL]Rep. Lois Frankel [D-FL]Rep. Dwight Evans [D-PA]
Rep. Joe Courtney [D-CT]Rep. Donald Norcross [D-NJ]Rep. Gwen Moore [D-WI]Rep. Daniel Kildee [D-MI]
Rep. Eleanor Norton [D-DC]Rep. James McGovern [D-MA]Rep. Peter Visclosky [D-IN]Rep. Salud Carbajal [D-CA]
Rep. Christopher Pappas [D-NH]Rep. Suzanne Bonamici [D-OR]Rep. Katie Hill [D-CA]Rep. Jahana Hayes [D-CT]
Rep. Matthew Cartwright [D-PA]Rep. Jerry McNerney [D-CA]Rep. Lisa Rochester [D-DE]Rep. Andy Kim [D-NJ]
Rep. David Trone [D-MD]Rep. Colin Allred [D-TX]Rep. Max Rose [D-NY]Rep. Mike Thompson [D-CA]
Rep. Grace Meng [D-NY]Rep. Steve Cohen [D-TN]Rep. Thomas Suozzi [D-NY]Rep. Susan Wild [D-PA]
Rep. Anna Eshoo [D-CA]Rep. Darren Soto [D-FL]Rep. Steven Horsford [D-NV]Rep. Filemon Vela [D-TX]
Rep. Joyce Beatty [D-OH]Rep. Debbie Wasserman Schultz [D-FL]Rep. William Keating [D-MA]Rep. Jared Golden [D-ME]
Rep. Adam Schiff [D-CA]Rep. Angela Craig [D-MN]Rep. Peter Welch [D-VT]Rep. Michael Doyle [D-PA]
Rep. Sylvia Garcia [D-TX]Rep. Danny Davis [D-IL]Rep. Raul Ruiz [D-CA]Rep. Doris Matsui [D-CA]
Rep. Elissa Slotkin [D-MI]Rep. Frederica Wilson [D-FL]Rep. David Loebsack [D-IA]Rep. Charlie Crist [D-FL]
Rep. Cheri Bustos [D-IL]Rep. Debbie Mucarsel-Powell [D-FL]Rep. Sean Casten [D-IL]Rep. Kim Schrier [D-WA]
Rep. Henry Cuellar [D-TX]Rep. Jennifer Wexton [D-VA]Rep. Emanuel Cleaver [D-MO]Rep. Janice Schakowsky [D-IL]
Rep. John Sarbanes [D-MD]Rep. Sean Maloney [D-NY]Rep. Al Lawson [D-FL]Rep. Dean Phillips [D-MN]
Rep. Bradley Schneider [D-IL]Rep. Gregory Meeks [D-NY]Rep. Adriano Espaillat [D-NY]Rep. Stephen Lynch [D-MA]
Rep. Brian Higgins [D-NY]Rep. James Langevin [D-RI]Rep. Judy Chu [D-CA]Rep. Haley Stevens [D-MI]
Rep. Ed Perlmutter [D-CO]Rep. Sharice Davids [D-KS]Rep. Cindy Axne [D-IA]Rep. Alcee Hastings [D-FL]
Rep. Don Beyer [D-VA]Rep. Nita Lowey [D-NY]Rep. Donald McEachin [D-VA]Rep. Norma Torres [D-CA]
Rep. Donald Payne [D-NJ]Rep. Mary Gay Scanlon [D-PA]Rep. Theodore Deutch [D-FL]Rep. John Yarmuth [D-KY]
Rep. Abigail Spanberger [D-VA]Rep. Hakeem Jeffries [D-NY]Rep. Lucy McBath [D-GA]Rep. Debbie Dingell [D-MI]
Rep. Abby Finkenauer [D-IA]Rep. John Garamendi [D-CA]Rep. Betty McCollum [D-MN]Rep. Marc Veasey [D-TX]
Rep. Joaquin Castro [D-TX]Rep. Vicente Gonzalez [D-TX]Rep. Karen Bass [D-CA]Rep. Sanford Bishop [D-GA]
Rep. Adam Smith [D-WA]Rep. Alan Lowenthal [D-CA]Rep. Elizabeth Fletcher [D-TX]

Roll Calls

2019-12-12 - House - On passage RC# 682 (Y: 230 N: 192 NV: 8 Abs: 0) [PASS]
2019-12-12 - House - On agreeing to the Cunningham amendment (A011) H.Amdt.721 RC# 680 (Y: 234 N: 192 NV: 10 Abs: 0) [PASS]
2019-12-12 - House - On motion to recommit with instructions RC# 681 (Y: 196 N: 226 NV: 8 Abs: 0) [FAIL]
2019-12-12 - House - On agreeing to the Luria amendment (A010) H.Amdt.720 RC# 679 (Y: 231 N: 192 NV: 13 Abs: 0) [PASS]
2019-12-12 - House - On agreeing to the Gottheimer amendment (A007) H.Amdt.717 RC# 678 (Y: 380 N: 45 NV: 11 Abs: 0) [PASS]
2019-12-12 - House - On agreeing to the Walden amendment (A001) H.Amdt.711 RC# 676 (Y: 201 N: 223 NV: 12 Abs: 0) [FAIL]
2019-12-12 - House - On agreeing to the O'Halleran amendment (A005) H.Amdt.715 RC# 677 (Y: 351 N: 73 NV: 12 Abs: 0) [PASS]

History

DateChamberAction
2019-12-16SenateReceived in the Senate.
2019-12-12HouseMotion to reconsider laid on the table Agreed to without objection.
2019-12-12HouseOn passage Passed by the Yeas and Nays: 230 - 192 (Roll no. 682).
2019-12-12HouseOn motion to recommit with instructions Failed by the Yeas and Nays: 196 - 226 (Roll no. 681).
2019-12-12HouseThe previous question on the motion to recommit with instructions was ordered without objection.
2019-12-12HouseDEBATE - The House proceeded with 10 minutes of debate on the Upton motion to recommit with instructions. The instructions contained in the motion seek to require the bill to be reported back to the House with an amendment to change the effective date of the Act until the Secretary of Health and Human Services certifies that the implementation of the provisions in the bill are not projected to result in fewer new drug applications with respect to unmet medical needs and life saving cures.
2019-12-12HouseMr. Upton moved to recommit with instructions to the Committee on Energy and Commerce. (text: CR H10223)
2019-12-12HouseThe House adopted the amendments en gross as agreed to by the Committee of the Whole House on the state of the Union.
2019-12-12HouseThe previous question was ordered pursuant to the rule.
2019-12-12HouseThe House rose from the Committee of the Whole House on the state of the Union to report H.R. 3.
2019-12-12HouseH.Amdt.721 On agreeing to the Cunningham amendment (A011) Agreed to by recorded vote: 234 - 192 (Roll no. 680).
2019-12-12HouseH.Amdt.720 On agreeing to the Luria amendment (A010) Agreed to by recorded vote: 231 - 192 (Roll no. 679).
2019-12-12HouseH.Amdt.717 On agreeing to the Gottheimer amendment (A007) Agreed to by recorded vote: 380 - 45 (Roll no. 678).
2019-12-12HouseH.Amdt.715 On agreeing to the O'Halleran amendment (A005) Agreed to by recorded vote: 351 - 73 (Roll no. 677).
2019-12-12HouseH.Amdt.711 On agreeing to the Walden amendment (A001) Failed by recorded vote: 201 - 223 (Roll no. 676).
2019-12-12HouseUNFINISHED BUSINESS - The Chair announced that the unfinished business was on adoption of amendments, which were debated earlier and on which further proceedings had been postponed.
2019-12-12HouseH.Amdt.722 On agreeing to the Houlahan amendment (A012) Agreed to by voice vote.
2019-12-12HouseDEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Houlahan amendment No. 12.
2019-12-12HouseH.Amdt.722 Amendment (A012) offered by Ms. Houlahan. (consideration: CR H10217-10219; text: CR H10217-10218)
2019-12-12HousePOSTPONED PROCEEDINGS - At the conclusion of debate on the Cunningham amendment the Chair put the question on adoption of the amendment and by voice vote, announced that the ayes had prevailed. Mr. Roe (TN) demanded a recorded vote and the Chair postponed further proceedings until a time to be announced.
2019-12-12HouseDEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Cunningham amendment No. 11.
2019-12-12HouseH.Amdt.721 Amendment (A011) offered by Mr. Cunningham. (consideration: CR H10216-10217, H10222; text: CR H10216)
2019-12-12HousePOSTPONED PROCEEDINGS - At the conclusion of debate on the Luria amendment the Chair put the question on adoption of the amendment and by voice vote, announced that the ayes had prevailed. Mr. Walden demanded a recorded vote and the Chair postponed further proceedings until a time to be announced.
2019-12-12HouseDEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Luria amendment No. 10.
2019-12-12HouseH.Amdt.720 Amendment (A010) offered by Mrs. Luria. (consideration: CR H10215-10216, H10221-10222; text: CR H10215)
2019-12-12HouseH.Amdt.719 On agreeing to the Finkenauer amendment (A009) Agreed to by voice vote.
2019-12-12HouseDEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Finkenauer amendment No. 9.
2019-12-12HouseH.Amdt.719 Amendment (A009) offered by Ms. Finkenauer. (consideration: CR H10214-10215; text: CR H10214)
2019-12-12HouseH.Amdt.718 On agreeing to the Axne amendment (A008) Agreed to by voice vote.
2019-12-12HouseDEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Axne amendment No. 8.
2019-12-12HouseH.Amdt.718 Amendment (A008) offered by Mrs. Axne. (consideration: CR H10211-10214; text: CR H10211-10213)
2019-12-12HousePOSTPONED PROCEEDINGS - At the conclusion of debate on the Gottheimer amendment the Chair put the question on adoption of the amendment and by voice vote, announced that the ayes had prevailed. Mr. Gottheimer demanded a recorded vote and the Chair postponed further proceedings until a time to be announced.
2019-12-12HouseDEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Gottheimer amendment No. 7.
2019-12-12HouseH.Amdt.717 Amendment (A007) offered by Mr. Gottheimer. (consideration: CR H10210-10211, H10221; text: CR H10210)
2019-12-12HouseH.Amdt.716 On agreeing to the Kennedy amendment (A006) Agreed to by voice vote.
2019-12-12HouseDEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Kennedy amendment No. 6.
2019-12-12HouseH.Amdt.716 Amendment (A006) offered by Mr. Kennedy. (consideration: CR H10208-10210; text: CR H10208)
2019-12-12HousePOSTPONED PROCEEDINGS - At the conclusion of debate on the O'Halleran amendment the Chair put the question on adoption of the amendment and by voice vote, announced that the ayes had prevailed. Mr. O'Halleran demanded a recorded vote and the Chair postponed further proceedings until a time to be announced.
2019-12-12HouseDEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the O'Halleran amendment No. 5.
2019-12-12HouseH.Amdt.715 Amendment (A005) offered by Mr. O'Halleran. (consideration: CR H10206-10208, H10220-10221; text: CR H10207)
2019-12-12HouseH.Amdt.714 On agreeing to the Kennedy amendment (A004) Agreed to by voice vote.
2019-12-12HouseDEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Kennedy amendment No. 4.
2019-12-12HouseH.Amdt.714 Amendment (A004) offered by Mr. Kennedy. (consideration: CR H10205-10206; text: CR H10205)
2019-12-12HouseH.Amdt.713 On agreeing to the Peters amendment (A003) Agreed to by voice vote.
2019-12-12HouseDEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Peters amendment No. 3.
2019-12-12HouseH.Amdt.713 Amendment (A003) offered by Mr. Peters. (consideration: CR H10204-10205; text: CR H10204)
2019-12-12HouseH.Amdt.712 On agreeing to the Tonko amendment (A002) Agreed to by voice vote.
2019-12-12HouseDEBATE - Pursuant to the provisions of H. Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Tonko amendment No. 2.
2019-12-12HouseH.Amdt.712 Amendment (A002) offered by Mr. Tonko. (consideration: CR H10202-10204; text: CR H10202-10203)
2019-12-12HousePOSTPONED PROCEEDINGS - At the conclusion of debate on the Walden amendment the Chair put the question on adoption of the amendment and by voice vote, announced that the noes had prevailed. Mr. Walden demanded a recorded vote and the Chair postponed further proceedings until a time to be announced.
2019-12-12HouseDEBATE - Pursuant to the provisions of H.Res. 758, the Committee of the Whole proceeded with 10 minutes of debate on the Walden amendment No. 1.
2019-12-12HouseH.Amdt.711 Amendment (A001) offered by Mr. Walden. (consideration: CR H10167-10202, H10219-10220; text: CR H10167-10201)
2019-12-12HouseGENERAL DEBATE - The Committee of the Whole proceeded with one hour of further debate on H.R. 3.
2019-12-12HouseThe House resolved into Committee of the Whole House on the state of the Union for further consideration.
2019-12-12HouseConsidered as unfinished business. (consideration: CR H10129-10225; text: CR H10141-10167)
2019-12-11HouseCommittee of the Whole House on the state of the Union rises leaving H.R. 3 as unfinished business.
2019-12-11HouseOn motion that the Committee rise Agreed to by voice vote.
2019-12-11HouseMr. Scott (VA) moved that the Committee rise.
2019-12-11HouseGENERAL DEBATE - The Committee of the Whole proceeded with four hours of general debate on H.R. 3.
2019-12-11HouseThe Speaker designated the Honorable Donald M. Payne, Jr. to act as Chairman of the Committee.
2019-12-11HouseHouse resolved itself into the Committee of the Whole House on the state of the Union pursuant to H. Res. 758 and Rule XVIII.
2019-12-11HouseThe rule provides for consideration of H.R. 3, under a structured rule, with 4 hours of general debate. The rule provides for consideration of H.R. 5038 under a closed rule, with 1 hour of general debate. The rule provides for consideration of the conference report to accompany S. 1790 with 1 hour of debate.
2019-12-11HouseConsidered under the provisions of rule H. Res. 758. (consideration: CR H10096-10117)
2019-12-10HouseRules Committee Resolution H. Res. 758 Reported to House. The rule provides for consideration of H.R. 3, under a structured rule, with 4 hours of general debate. The rule provides for consideration of H.R. 5038 under a closed rule, with 1 hour of general debate. The rule provides for consideration of the conference report to accompany S. 1790 with 1 hour of debate.
2019-12-09HousePlaced on the Union Calendar, Calendar No. 264.
2019-12-09HouseReported (Amended) by the Committee on Education and Labor. H. Rept. 116-324, Part III.
2019-12-06HouseHouse Committee on Education and Labor Granted an extension for further consideration ending not later than Dec. 9, 2019.
2019-12-06HouseReported (Amended) by the Committee on Ways and Means. H. Rept. 116-324, Part II.
2019-12-06HouseReported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-324, Part I.
2019-10-22HouseOrdered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 24 - 17.
2019-10-22HouseCommittee Consideration and Mark-up Session Held.
2019-10-17HouseOrdered to be Reported (Amended) by the Yeas and Nays: 27 - 21.
2019-10-17HouseCommittee Consideration and Mark-up Session Held.
2019-09-25HouseSubcommittee Hearings Held.
2019-09-20HouseReferred to the Subcommittee on Health.
2019-09-19HouseReferred to the Subcommittee on Health.
2019-09-19HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-09-19HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-09-19HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-09-19HouseIntroduced in House

Same As/Similar To

HB4619 (Related) 2019-10-09 - Referred to the Subcommittee on Health.
HB4649 (Related) 2019-10-30 - Sponsor introductory remarks on measure. (CR H8607)
HB4663 (Related) 2019-10-14 - Referred to the Subcommittee on Health.
HR758 (Related) 2019-12-11 - Mr. Nadler moved to table the motion to reconsider
HB2296 (Related) 2019-09-24 - Placed on the Union Calendar, Calendar No. 170.
HB3339 (Related) 2019-06-19 - Referred to the House Committee on Ways and Means.
HB3343 (Related) 2019-06-19 - Referred to the House Committee on Ways and Means.
HB3347 (Related) 2019-06-19 - Referred to the House Committee on Ways and Means.
HB3398 (Related) 2019-10-29 - Placed on the Union Calendar, Calendar No. 211.
HB4455 (Related) 2019-09-23 - Referred to the Subcommittee on Health.
HB4618 (Related) 2020-01-24 - Placed on the Union Calendar, Calendar No. 302.
HB4629 (Related) 2019-10-18 - Sponsor introductory remarks on measure. (CR H8232)
HB4633 (Related) 2019-10-14 - Referred to the Subcommittee on Health.
HB4650 (Related) 2020-01-24 - Placed on the Union Calendar, Calendar No. 303.
HB4661 (Related) 2019-10-17 - Sponsor introductory remarks on measure. (CR H8207)
HB4665 (Related) 2020-01-24 - Placed on the Union Calendar, Calendar No. 304.
HB4666 (Related) 2019-10-14 - Referred to the Subcommittee on Health.
HB4669 (Related) 2019-10-14 - Referred to the Subcommittee on Health.
HB4675 (Related) 2019-10-16 - Referred to the Subcommittee on Health.
HB4676 (Related) 2019-10-16 - Referred to the Subcommittee on Health.
HB4768 (Related) 2019-10-22 - Referred to the Subcommittee on Health.
HB4835 (Related) 2019-10-23 - Referred to the House Committee on Education and Labor.
HB5281 (Related) 2019-12-04 - Referred to the Subcommittee on Health.
SB1260 (Related) 2019-05-01 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
HB5357 (Related) 2019-12-09 - Referred to the Subcommittee on Health.
HB5688 (Related) 2020-01-28 - Referred to the House Committee on Energy and Commerce.
SB3376 (Related) 2020-03-03 - Read twice and referred to the Committee on Finance.

Subjects

Accounting and auditing
Administrative law and regulatory procedures
Adult education and literacy
Cancer
Centers for Disease Control and Prevention (CDC)
Child care and development
Child health
Civil actions and liability
Congressional oversight
Criminal justice information and records
Dental care
Department of Health and Human Services
Digestive and metabolic diseases
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Education of the disadvantaged
Education programs funding
Elementary and secondary education
Employee hiring
Employment and training programs
Executive agency funding and structure
Food and Drug Administration (FDA)
Government information and archives
Government studies and investigations
Health
Health care costs and insurance
Health care coverage and access
Health care quality
Health facilities and institutions
Health information and medical records
Health personnel
Health programs administration and funding
Health promotion and preventive care
Health technology, devices, supplies
Hearing, speech, and vision care
Indian social and development programs
Inflation and prices
Manufacturing
Marketing and advertising
Medicaid
Medical education
Medical tests and diagnostic methods
Medicare
Mental health
Minority health
National Institutes of Health (NIH)
Performance measurement
Prescription drugs
Public contracts and procurement
Public-private cooperation
Research administration and funding
Rural conditions and development
Sales and excise taxes
Sex and reproductive health
State and local government operations
U.S. territories and protectorates
Veterans' education, employment, rehabilitation
Women's health

US Congress State Sources


Bill Comments

feedback